Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Efficacy of Topical Sialogogue Spray (1% Malic Acid) for Antidepressant Induced Dry Mouth
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Efficacy of Topical Sialogogue Spray (1% Malic Acid) for Antidepressant Induced Dry Mouth
Antidepressant Induced Dry Mouth:
Efficacy of Topical Sialogogue Spray (containing 1% Malic Acid)
The aim of this study was to evaluate the clinical efficacy of a topical sialogogue spray containing 1% malic acid on patients affected by dry mouth caused by antidepressants drug.
MATERIALS AND METHODS:
* double-blind, randomized clinical trial at Faculty of Dentistry of University of Granada (Spain).
* n= 17 participants with antidepressant-induced dry mouth were divided into two groups=
FIRST "intervention group": 35 subjects- topical sialogogue spray (1% malic acid) was applied
SECOND "control group": 35 subjects- placebo spray was applied
* for both groups, the sprays were applied on demand during 2 weeks.
* Dry Mouth Questionnaire (DMQ) was used to evaluate dry mouth symptoms before and after product/placebo application.
* Unstimulated and stimulated salivary flows rates, before and after application, were measured.
RESULTS:
* Dry mouth symptoms improved after 1% malic acid topical spray application (p < .05).
* After 2 weeks of 1% malic acid application, unstimulated and stimulated salivary flows rates increased significantly (p < .05).
CONCLUSIONS:
A sialogogue spray containing 1% malic acid improved dry mouth feeling of the patients suffering antidepressant-induced dry mouth and increased unstimulated and stimulated salivary flows rates.
Source: Depress Anxiety. 2013. Feb;30(2):137-42.
Similar topics
» Normalization of Risperidone-Induced Hyperprolactinemia with the Addition of Aripiprazole
» Efficacy Among Second-Generation Antidepressants is About the Same
» Efficacy of Antipsychotics in Pediatric Acute Mania
» An Update on Antidepressant Use in Bipolar Depression
» Viibryd- New Antidepressant approved by FDA recently
» Efficacy Among Second-Generation Antidepressants is About the Same
» Efficacy of Antipsychotics in Pediatric Acute Mania
» An Update on Antidepressant Use in Bipolar Depression
» Viibryd- New Antidepressant approved by FDA recently
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin